Figure 3From: The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expressionEffects of GAS5 plus gefitinib on cell proliferation in gefitinib-resistant A549 cells. (A) Representative EdU results of four groups. (B) Effects of GAS5 plus gefitinib on EdU+ stained cells at 6 h after treatment. The data represent the mean ± SD from three independent experiments. **P < 0.01Back to article page